8000 MARINA BLVD, BRISBANE, CA
Amended material disclosure
Earnings Release
Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
CareDx, Inc. Approves Amendment to 2024 Equity Incentive Plan
Announces First Quarter 2026 Financial Results, Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
Annual Report to Security Holders
Material Contracts, Financial Results, Reg. FD
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement